These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38233304)

  • 1. Outpatient administration of high-dose methotrexate in adults without drug monitoring - a case-control study of risk factors for acute kidney injury.
    Alves C; Pereira J; Rego EM; Rocha V; Silva WF
    Hematol Transfus Cell Ther; 2023 Dec; ():. PubMed ID: 38233304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended duration of prehydration does not prevent nephrotoxicity or delayed drug elimination in high-dose methotrexate infusions: a prospectively randomized cross-over study.
    Mikkelsen TS; Mamoudou AD; Tuckuviene R; Wehner PS; Schroeder H
    Pediatr Blood Cancer; 2014 Feb; 61(2):297-301. PubMed ID: 24039194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a model to predict acute kidney injury following high-dose methotrexate in patients with lymphoma.
    Rice ML; Barreto EF; Rule AD; Martin CE; Truong HL; Mara KC; Kashani KB; Thompson CA; Witzig TE; Barreto JN
    Pharmacotherapy; 2024 Jan; 44(1):4-12. PubMed ID: 37926860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early, empiric high-dose leucovorin rescue in lymphoma patients treated with sequential doses of high-dose methotrexate.
    Barreto JN; Peterson KT; Barreto EF; Mara KC; Dierkhising RA; Leung N; Witzig TE; Thompson CA
    Support Care Cancer; 2021 Sep; 29(9):5293-5301. PubMed ID: 33661366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.
    Totadri S; Srinivasan HN; Joseph LL; Boddu D; Mathew LG; John R
    Pediatr Hematol Oncol; 2021 Aug; 38(5):434-443. PubMed ID: 33764242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is hypoalbuminemia a risk factor for high-dose methotrexate toxicity in children with acute lymphoblastic leukemia?
    Barakat S; Assem H; Salama M; Mikhael N; El Chazli Y
    J Egypt Natl Canc Inst; 2022 Apr; 34(1):17. PubMed ID: 35434757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes is a risk factor for high-dose methotrexate-associated AKI in lymphoma patients.
    Wang Y; Wei L; Guan Y; Wang Q; Xie Q; Hao C
    Ren Fail; 2020 Nov; 42(1):1111-1117. PubMed ID: 33164656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of drug interaction between levetiracetam and high-dose methotrexate in patients with lymphoma.
    DeFino CE; Barreto JN; Pawlenty AG; Ruff MW; Carabenciov ID; Mara KC; Thompson CA
    Pharmacotherapy; 2021 May; 41(5):430-439. PubMed ID: 33655525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study.
    Gros L; Roldán A; Cabero-Martínez A; Domínguez-Pinilla N; de la Fuente A; González-Barca E; Tasso M; Torrent M; Gallardo E; Del Cerro I; Giró-Perafita A; Badia X
    J Oncol Pharm Pract; 2023 Jun; 29(4):794-801. PubMed ID: 35147457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for high-dose methotrexate associated acute kidney injury in patients with hematological malignancies.
    Amitai I; Rozovski U; El-Saleh R; Shimony S; Shepshelovich D; Rozen-Zvi B; Raanani P; Gafter-Gvili A; Gurion R
    Hematol Oncol; 2020 Oct; 38(4):584-588. PubMed ID: 32506594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for predicting high dose methotrexate associated acute kidney injury in children with acute lymphoblastic leukemia.
    Li H; Xu Q; Wang Y; Chen K; Li J
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):95-103. PubMed ID: 31676986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Risk Factors in High-Dose Methotrexate-Induced Acute Kidney Injury in Childhood Acute Lymphoblastic Leukemia.
    Cheng DH; Lu H; Liu TT; Zou XQ; Pang HM
    Chemotherapy; 2018 Apr; 63(2):101-107. PubMed ID: 29672292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-Dose Methotrexate in Pediatric Acute Lymphoblastic Leukemia: Predictors of Delayed Clearance and the Effect of Increased Hydration Rate on Methotrexate Clearance.
    Chen AR; Wang YM; Lin M; Kuo DJ
    Cureus; 2020 Jun; 12(6):e8674. PubMed ID: 32699674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcoma.
    Fox E; Busch C; DeBernardo A; Segers B; Gottschalk J; Womer R; Balamuth N; Bagatell R; Balis F
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):807-815. PubMed ID: 33677616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for acute kidney injury after high-dose methotrexate therapy: a single-center study and narrative review.
    Liang CA; Su YC; Lin SJ; Tsai TH
    Eur J Clin Pharmacol; 2023 Jun; 79(6):789-800. PubMed ID: 37060460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma.
    Tsurusawa M; Gosho M; Mori T; Mitsui T; Sunami S; Kobayashi R; Fukano R; Tanaka F; Fujita N; Inada H; Koh K; Takimoto T; Saito A; Fujimoto J; Nakazawa A; Horibe K;
    Pediatr Blood Cancer; 2015 Feb; 62(2):279-284. PubMed ID: 25359701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
    Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
    Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safe administration of high-dose methotrexate with minimal drug level monitoring: Experience from a center in north India.
    Dhingra H; Kalra M; Mahajan A
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28394. PubMed ID: 32813334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early clinical indicators of acute kidney injury caused by administering high-dose methotrexate therapy to juvenile pigs.
    Buddington RK; Wong T; Buddington KK; Mikkelsen TS; Cao X; Howard SC
    Front Nephrol; 2023; 3():1193494. PubMed ID: 37790293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Application of
    Wang L; Chen K; Xu Q
    Biomed Res Int; 2020; 2020():3687134. PubMed ID: 33299868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.